Description
Holista CollTech Ltd. engages in the research & development, manufacture, and marketing of natural ingredients and wellness products. It operates through the following segments: Supplements, Ovine Collagen, Infection Control Solutions and Food Ingredients. The company was founded by Rajen Manicka on September 18, 2000 and is headquartered in Perth, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.01 - 0.03
Trade Value (12mth)
AU$291.00
1 week
0%
1 month
33.33%
YTD
-58.62%
1 year
-57.14%
All time high
2.20652
EPS 3 yr Growth
73.300%
EBITDA Margin
-13.90%
Operating Cashflow
-$1m
Free Cash Flow Return
-27.30%
ROIC
-35.70%
Interest Coverage
-17.20
Quick Ratio
0.90
Shares on Issue (Fully Dilluted)
279m
HALO Sector
Healthcare
Next Company Report Date
28-Feb-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 October 23 |
Quarterly Activity and Cashflow Report
×
Quarterly Activity and Cashflow Report |
31 May 23 |
AGM Presentation
×
AGM Presentation |
31 May 23 |
Results of Meeting
×
Results of Meeting |
31 May 22 |
AGM Presentation
×
AGM Presentation |
31 May 22 |
Results of Meeting
×
Results of Meeting |
31 March 23 |
Annual Report to shareholders
×
Annual Report to shareholders |
31 March 23 |
Appendix 4G
×
Appendix 4G |
31 March 22 |
Annual Report to shareholders
×
Annual Report to shareholders |
31 March 22 |
Appendix 4G
×
Appendix 4G |
31 March 21 |
Annual Report
×
Annual Report |
31 March 20 |
Annual Report to shareholders
×
Annual Report to shareholders |
31 July 23 |
Quarterly Activity and Cashflow Report
×
Quarterly Activity and Cashflow Report |
31 July 20 |
AGM Presentation
×
AGM Presentation |
31 July 20 |
Results of Annual General Meeting
×
Results of Annual General Meeting |
31 January 23 |
Quarterly Activity and Cashflow Report
×
Quarterly Activity and Cashflow Report |
31 August 23 |
Appendix 4D - Half Year Report
×
Appendix 4D - Half Year Report |
30 September 16 |
Annual Report to shareholders
×
Annual Report to shareholders |
30 September 11 |
Annual Report to shareholders
×
Annual Report to shareholders |
30 May 19 |
HCT AGM 2019 Presentation
×
HCT AGM 2019 Presentation |
30 June 21 |
Notice of Annual General Meeting / Proxy Form
×
Notice of Annual General Meeting / Proxy Form |
30 June 20 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
30 July 21 |
AGM Presentation
×
AGM Presentation |
30 July 21 |
Results of 2021 Annual General Meeting
×
Results of 2021 Annual General Meeting |
30 August 22 |
Appendix 4D and Interim Financial Report
×
Appendix 4D and Interim Financial Report |
30 August 22 |
Record Interim Revenue and Improved Earnings
×
Record Interim Revenue and Improved Earnings |
29 March 19 |
Annual Report to shareholders
×
Annual Report to shareholders |
29 March 18 |
Annual Report to shareholders
×
Annual Report to shareholders |
29 April 22 |
Test Results on All-Natural Nano Silver Disinfectant
×
Test Results on All-Natural Nano Silver Disinfectant |
29 April 22 |
Letter to Shareholders
×
Letter to Shareholders |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.